Rossari Biotech Limited has reported Consolidated financial results for the period ended June 30, 2024.
Financial Results (Q1 FY2025) - QoQ Comparison
The company has reported total income of Rs. 490.598 crores during the period ended June 30, 2024 as compared to Rs. 473.105 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs. 34.899 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 34.132 crores for the period ended March 31, 2024.
The company has reported EPS of Rs. 6.30 for the period ended June 30, 2024 as compared to Rs. 6.17 for the period ended March 31, 2024.
| Total Income | ₹ 490.598 crs | ₹473.105 crs |  3.70% | | Net Profit | ₹34.899 crs | ₹34.132 crs | 2.25% | | EPS | ₹6.30 | ₹6.17 | 2.11% |
Financial Results (Q1 FY2025) - YoY Comparison
The company has reported total income of Rs. 490.598 crores during the period ended June 30, 2024 as compared to Rs.412.796 crores during the period ended June 30, 2023.
The company has posted net profit / (loss) of Rs.34.899 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.29.219 crores for the period ended June 30, 2023.
The company has reported EPS of Rs.6.30 for the period ended June 30, 2024 as compared to Rs.5.28 for the period ended June 30, 2023.
| Total Income | ₹ 490.598 crs | ₹412.796 crs | 18.85% | | Net Profit | ₹34.899 crs | ₹29.219 crs | 19.44% | | EPS | ₹6.30 | ₹5.28 | 19.32% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 798.60 as compared to the previous close of Rs. 814.65. The total number of shares traded during the day was 13601 in over 1528 trades.
The stock hit an intraday high of Rs. 815.00 and intraday low of 790.50. The net turnover during the day was Rs. 10856454.00. |
